default author photo

Sharana Mahomed

University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA)

SCHOLARLY PAPERS

2

DOWNLOADS

196

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Fixed Dosing Versus Weight-Based Dosing of HIV-1 Prophylactic Monoclonal Antibodies in Adults: A Pharmacokinetics Modeling Study

Number of pages: 23 Posted: 14 Jan 2025
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, FHI 360 (Family Health International), HPTN Leadership and Operations Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Fred Hutchinson Cancer Research Center, Harvard University - Brigham and Women’s Hospital, University of North Carolina (UNC) at Chapel Hill - School of Medicine, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Kelly Government Solutions, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Irving Medical Center, Emory University - School of Medicine, University of North Carolina (UNC) at Chapel Hill, Harvard University - Beth Israel Deaconess Medical Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Emory University - Division of Infectious Diseases, University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA), George Washington University - School of Medicine and Health Sciences, National Institutes of Health, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of North Carolina (UNC) at Chapel Hill - Department of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, National Institutes of Health - Vaccine Research Center and Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology
Downloads 111 (645,052)

Abstract:

Loading...

HIV prevention, dosing strategy, exponent of body weight, two-compartment, population pharmacokinetics model, variability in exposure

2.

Safety, Pharmacokinetics, and Neutralization Activity of PGDM1400LS, VRC07-523-LS, and PGT121.414.LS Infused Intravenously or Subcutaneously: A Phase 1 Randomized Trial (HVTN 140/HPTN 101 Part B)

Number of pages: 37 Posted: 18 Jul 2025
University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA), Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, HPTN Leadership and Operations Center, Duke University, Duke University, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center, National Institutes of Health, Kelly Government Solutions, University of North Carolina (UNC) at Chapel Hill - Division of Chemical Biology and Medicinal Chemistry, Fred Hutchinson Cancer Research Center, Johns Hopkins University, FHI 360, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Vanderbilt University - Division of Infectious Diseases, San Francisco Department of Health, University of the Witwatersrand, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), University of Cape Town, Wits Health Consortium - Perinatal HIV Research Unit (PHRU), University of Zimbabwe - Faculty of Medicine and Health Sciences, University of Zimbabwe, University of Zimbabwe, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, Dartmouth College, Dartmouth College - Thayer School of Engineering, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases, Harvard Medical School - Beth Israel Deaconess Medical Center - Center for Virology and Vaccine Research, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of North Carolina (UNC) at Chapel Hill - Department of Medicine, Duke University - Duke Human Vaccine Institute, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, George Washington University - School of Medicine and Health Sciences, Emory University - Division of Infectious Diseases and Independent
Downloads 85 (783,685)

Abstract:

Loading...

HIV, monoclonal antibodies, passive immunization, PGDM1400LS, VRC07-523LS, PGT121.414.LS